Northwestern Mutual Investment Management Company’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$784K Buy
10,453
+43
+0.4% +$2.76K 0.01% 697
2026
Q1
$587K Sell
10,410
-63
-0.6% -$4.1K 0.01% 753
2025
Q4
$839K Sell
10,473
-265
-2% -$17.8K 0.01% 645
2025
Q3
$523K Sell
10,738
-479
-4% -$29.6K 0.01% 767
2025
Q2
$837K Buy
11,217
+47
+0.4% +$3.11K 0.01% 613
2025
Q1
$710K Buy
11,170
+8
+0.1% +$544 0.01% 670
2024
Q4
$872K Sell
11,162
-193
-2% -$15.5K 0.02% 611
2024
Q3
$913K Buy
11,355
+19
+0.2% +$1.53K 0.02% 602
2024
Q2
$938K Buy
11,336
+9
+0.1% +$792 0.02% 559
2024
Q1
$967K Buy
11,327
+38
+0.3% +$2.98K 0.03% 554
2023
Q4
$965K Buy
11,289
+43
+0.4% +$3.72K 0.03% 539
2023
Q3
$1.01M Buy
11,246
+35
+0.3% +$3.13K 0.03% 457
2023
Q2
$955K Buy
11,211
+18
+0.2% +$1.52K 0.02% 500
2023
Q1
$926K Buy
11,193
+6,510
+139% +$527K 0.02% 494
2022
Q4
$368K Sell
4,683
-2,728
-37% -$219K 0.01% 666
2022
Q3
$549K Sell
7,411
-1,144
-13% -$82.1K 0.01% 592
2022
Q2
$558K Buy
8,555
+66
+0.8% +$3.91K 0.01% 675
2022
Q1
$537K Buy
8,489
+17
+0.2% +$924 0.01% 761
2021
Q4
$449K Buy
8,472
+53
+0.6% +$3.23K 0.01% 839
2021
Q3
$594K Sell
8,419
-67
-0.8% -$4.23K 0.01% 718
2021
Q2
$566K Buy
8,486
+8
+0.1% +$566 0.01% 753
2021
Q1
$941K Sell
8,478
-8,980
-51% -$1.11M 0.02% 485
2020
Q4
$2.07M Sell
17,458
-75
-0.4% -$8.07K 0.03% 297
2020
Q3
$1.57M Hold
17,533
0.02% 331
2020
Q2
$1.57M Sell
17,533
-67
-0.4% -$6.77K 0.02% 330
2020
Q1
$1.75M Buy
17,600
+3,124
+22% +$339K 0.03% 238
2019
Q4
$1.66M Hold
14,476
0.03% 286
2019
Q3
$1.83M Sell
14,476
-128
-0.9% -$16.2K 0.04% 231
2019
Q2
$1.76M Buy
14,604
+5,529
+61% +$544K 0.04% 237
2019
Q1
$794K Sell
9,075
-695
-7% -$63.2K 0.01% 653
2018
Q4
$977K Buy
9,770
+27
+0.3% +$2.84K 0.02% 571
2018
Q3
$1.12M Sell
9,743
-518
-5% -$53.6K 0.02% 591
2018
Q2
$920K Buy
+10,261
New +$867K 0.01% 670

Other funds holding HAE

Northwestern Mutual Investment Management Company's HAE Position: Q2 2026 in Review

Northwestern Mutual Investment Management Company increased its Haemonetics (HAE) stake by 0.41% in Q2 2026, buying an estimated $2.76K and bringing the position to 10,453 shares worth $784K. The position accounts for 0.01% of the portfolio, ranked #697.

Northwestern Mutual Investment Management Company first reported a position in HAE in Q2 2018 and has held it in 33 quarters since. The position peaked at $2.07M in Q4 2020. 212 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Northwestern Mutual Investment Management Company held 10,453 shares of Haemonetics worth $784K as of Q2 2026.
  • Northwestern Mutual Investment Management Company bought 43 Haemonetics shares in Q2 2026, an estimated $2.76K.
  • Haemonetics made up 0.01% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #697 holding.
  • Northwestern Mutual Investment Management Company first reported a position in Haemonetics in Q2 2018 and has held it in 33 quarters since.
  • Northwestern Mutual Investment Management Company's Haemonetics position peaked at $2.07M in Q4 2020.
  • 212 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.